Community Health Proposes $1.244 Billion Bond Exchange for Notes Due in 2029
Key Facts
On November 10, 2026, Community Health Systems announced its intention to launch a private exchange offer involving about $1.244 billion of its 6.875% senior secured notes due in 2029 for new 10.250% senior secured notes due in 2035, according to a Business Wire summary. The proposal moves the maturity of this tranche six years beyond that of the existing notes, with a higher stated interest rate. However, the full offer terms could not be verified through the original public release. The company’s filing with the U.S. Securities and Exchange Commission showed that the balance of the 2029 notes was $1.244 billion on September 30, 2026. The announcement comes as the company faces weaker operating results and a third-quarter net loss.
The proposed notes’ figures indicate that the new tranche carries a higher annual interest rate than the notes due in 2029, while extending the maturity date to 2035, according to a Business Wire summary. The publicly available materials did not include verified details on the participation terms, the offer timeline or its expected effect on interest expense. The official filing therefore confirms the balance of the existing notes and their maturity date, while the proposed issuance terms appear in the news summary. The available filing does not include an explanation from the company for the transaction. The proposal follows a series of debt-management moves by the company in 2026, including bond buybacks funded with divestiture proceeds.
On October 28, the company reported operating revenue of $2.757 billion in the third quarter, down 10.7% from $3.087 billion in the same period of 2025. By contrast, same-store hospital revenue rose 3.8% year over year. The company recorded a net loss attributable to shareholders of $86 million, or $0.63 per diluted share, compared with net income of $130 million, or $0.96 per share, a year earlier. Chief Executive Kevin Hammons said activity volumes and cash flows improved sequentially in the third quarter. He added, however, that payer mix and case acuity did not develop as the company had expected amid a challenging macroeconomic environment, adversely affecting results and the outlook for the rest of the year.
The company cut its outlook for the year ending December 31, 2026, setting operating revenue at between $11.3 billion and $11.5 billion, and adjusted earnings before interest, taxes, depreciation and amortization at between $1.225 billion and $1.275 billion. It also expects diluted per-share losses of between $1.60 and $1.70. Hammons linked pressure on the outlook to payer mix and case acuity, as well as the challenging macroeconomic environment. The forecast puts the estimated annual per-share loss in the context of the third-quarter result, which included a loss of $0.63 per diluted share. The available materials provided no further details on the proposed bond exchange’s effect on that outlook.
The company previously used about $600 million in cash proceeds from divestitures to repurchase notes in a transaction that began on April 22 and was completed on May 6, 2026. The transaction included about $368 million of notes bearing 4.750% interest and due in 2031, and about $231 million of notes bearing 10.875% interest and due in 2032, according to the company’s quarterly report filed with the U.S. Securities and Exchange Commission. During 2026 through the date of its third-quarter results release, the company divested its 80% interest in one hospital, as well as nine other hospitals. One of the other hospital divestitures took effect on October 1, 2026. In the market, the company’s shares closed at $2.21 on November 6, according to EL7 data, before the offer was announced on November 10.